Biocondensates fuel tumor immune evasion

被引:0
|
作者
Kubelick, Kelsey P. [1 ,2 ,3 ]
Quiroz, Felipe Garcia [1 ,2 ]
机构
[1] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA
[2] Emory Univ, Atlanta, GA 30322 USA
[3] Georgia Inst Technol, Sch Elect & Comp Engn, Atlanta, GA USA
关键词
D O I
10.1038/s43018-023-00520-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Transactivation hubs and related biomolecular condensates are emerging as relevant molecular players in cancer biology. A new study now links PD-L1 upregulation on the cancer cell surface and IRF1-KAT8 transactivation hubs at PD-L1 loci. Therapeutic targeting of these hubs holds potential to unleash antitumor immunity.
引用
收藏
页码:312 / 314
页数:3
相关论文
共 50 条
  • [41] Emerging role of metabolic reprogramming in tumor immune evasion and immunotherapy
    Chunmei Fan
    Shanshan Zhang
    Zhaojian Gong
    Xiayu Li
    Bo Xiang
    Hao Deng
    Ming Zhou
    Guiyuan Li
    Yong Li
    Wei Xiong
    Zhaoyang Zeng
    Xiaoling Li
    Science China Life Sciences, 2021, 64 : 534 - 547
  • [42] Interferon-Gamma at the Crossroads of Tumor Immune Surveillance or Evasion
    Castro, Flavia
    Cardoso, Ana Patricia
    Goncalves, Raquel Madeira
    Serre, Karine
    Oliveira, Maria Jose
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [43] The multifaceted role of autophagy in tumor evasion from immune surveillance
    Janji, Bassam
    Viry, Elodie
    Moussay, Etienne
    Paggetti, Jerome
    Arakelian, Tsolere
    Mgrditchian, Takouhie
    Messai, Yosra
    Noman, Muhammad Zaeem
    Van Moer, Kris
    Hasmim, Meriem
    Mami-Chouaib, Fathia
    Berchem, Guy
    Chouaib, Salem
    ONCOTARGET, 2016, 7 (14) : 17591 - 17607
  • [44] Cancer-Associated Fibroblasts: Accomplices in the Tumor Immune Evasion
    Hilmi, Marc
    Nicolle, Remy
    Bousquet, Corinne
    Neuzillet, Cindy
    CANCERS, 2020, 12 (10) : 1 - 23
  • [45] Is CD47 an innate immune checkpoint for tumor evasion?
    Xiaojuan Liu
    Hyunwoo Kwon
    Zihai Li
    Yang-xin Fu
    Journal of Hematology & Oncology, 10
  • [46] Is CD47 an innate immune checkpoint for tumor evasion?
    Liu, Xiaojuan
    Kwon, Hyunwoo
    Li, Zihai
    Fu, Yang-xin
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2017, 10 : 1 - 7
  • [47] ANTIGEN EVASION AS A MECHANISM FOR TUMOR ESCAPE FROM IMMUNE DESTRUCTION
    STACKPOLE, CW
    CREMONA, P
    LEONARD, C
    STREMMEL, P
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 242 - 242
  • [48] Immunoediting instructs tumor metabolic reprogramming to support immune evasion
    Tsai, Chin-Hsien
    Chuang, Yu-Ming
    Li, Xiaoyun
    Yu, Yi-Ru
    Tzeng, Sheue-Fen
    Teoh, Shao Thing
    Lindblad, Katherine E.
    Di Matteo, Mario
    Cheng, Wan-Chen
    Hsueh, Pei-Chun
    Kao, Kung-Chi
    Imrichova, Hana
    Duan, Likun
    Gallart-Ayala, Hector
    Hsiao, Pei-Wen
    Mazzone, Massimiliano
    Ivanesevic, Julijana
    Liu, Xiaojing
    de Visser, Karin E.
    Lujambio, Amaia
    Lunt, Sophia Y.
    Kaech, Susan M.
    Ho, Ping-Chih
    CELL METABOLISM, 2023, 35 (01) : 118 - +
  • [49] Delineating the epigenetic vulnerabilities of tumor immune evasion for combination immunotherapy
    Cheng, Alfred
    CANCER SCIENCE, 2021, 112 : 1045 - 1045
  • [50] MYC AMPLIFICATION STATUS INFLUENCES TUMOR IMMUNE EVASION IN MEDULLOBLASTOMA
    Martin, Allison
    Nirschl, Christopher
    Polanczyk, Magda
    Cohen, Kenneth
    Pardoll, Drew
    Drake, Charles
    Lim, Michael
    NEURO-ONCOLOGY, 2013, 15 : 15 - 16